Travere Therapeutics, Inc. (TVTX) Financials

TVTX Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 799.4 million 774.8 million
March 31, 2026 555.2 million 456.5 million
Dec. 31, 2025 605.2 million 490.4 million
Sept. 30, 2025 538.6 million 465.0 million

TVTX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 80.2 million 21.8 million
March 31, 2026 -62.5 million 16.1 million
Dec. 31, 2025 41.8 million 11.5 million
Sept. 30, 2025 14.2 million 11.3 million

TVTX Net Income

No data available :(

TVTX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 489.2 million 602.8 million 8.0 million
March 31, 2026 264.7 million 312.1 million 15.6 million
Dec. 31, 2025 322.8 million 322.9 million 11.1 million
Sept. 30, 2025 254.5 million 311.4 million 18.4 million

TVTX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 93.5 million
March 31, 2026 91.9 million
Dec. 31, 2025 90.3 million
Sept. 30, 2025 102.6 million

TVTX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 22.2 million 60.3 million 96.1 million -
March 31, 2026 22.2 million 57.1 million 80.3 million -
Dec. 31, 2025 18.9 million 57.9 million 101.7 million -
Sept. 30, 2025 140000 51.9 million 86.5 million -

TVTX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 169.6 million 2.2 million
March 31, 2026 127.2 million 26.8 million
Dec. 31, 2025 129.7 million 2.6 million
Sept. 30, 2025 164.9 million 1.6 million

TVTX Revenue by Segment
Graph available only for paid members. Upgrade to see it.

TVTX

Price: $62.14

52 week price:
15.60
66.24

Earnings Per Share: -0.72 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 1.1 million

Market Capitalization: 5.7 billion

Links: